Derek C Cole

Summary

Affiliation: Wyeth Research
Country: USA

Publications

  1. ncbi Modification of the swern oxidation: use of a recyclable, polystyrene bound sulfoxide
    Derek C Cole
    Chemical Sciences, Wyeth Research, 401N Middletown Rd, Pearl River, NY 10965, USA
    Bioorg Med Chem Lett 12:1791-3. 2002
  2. ncbi (S)-N-(5-Chlorothiophene-2-sulfonyl)-beta,beta-diethylalaninol a Notch-1-sparing gamma-secretase inhibitor
    Derek C Cole
    Chemical and Screening Sciences, Wyeth Research, Pearl River, NY 10965, USA
    Bioorg Med Chem Lett 19:926-9. 2009
  3. ncbi Identification, characterization and initial hit-to-lead optimization of a series of 4-arylamino-3-pyridinecarbonitrile as protein kinase C theta (PKCtheta) inhibitors
    Derek C Cole
    Chemical and Screening Sciences, Wyeth Research, Pearl River, New York 10965, USA
    J Med Chem 51:5958-63. 2008
  4. ncbi Benzimidazole- and indole-substituted 1,3'-bipyrrolidine benzamides as histamine H3 receptor antagonists
    Derek C Cole
    Chemical Sciences, Wyeth Research, 401 N Middletown Rd Pearl River, NY 10965, United States
    Bioorg Med Chem Lett 20:1237-40. 2010
  5. ncbi Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1 and S3 substrate binding pockets
    Derek C Cole
    Chemical and Screening Sciences, Wyeth Research, 401 N Middletown Road, Pearl River, NY 10965, USA
    Bioorg Med Chem Lett 18:1063-6. 2008
  6. ncbi Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonist
    Derek C Cole
    Chemical and Screening Sciences, Wyeth Research, 401 N Middletown Road, Pearl River, New York 10965, USA
    J Med Chem 50:5535-8. 2007
  7. ncbi N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists
    Derek C Cole
    Chemical and Screening Sciences, Wyeth Research, Pearl River, NY 10965, USA
    Bioorg Med Chem Lett 15:379-83. 2005
  8. ncbi Discovery of 5-arylsulfonamido-3-(pyrrolidin-2-ylmethyl)-1H-indole derivatives as potent, selective 5-HT6 receptor agonists and antagonists
    Derek C Cole
    Chemical and Screening Sciences, Wyeth Research, 401 N Middletown Road, Pearl River, New York 10965, USA
    J Med Chem 48:353-6. 2005
  9. ncbi Conformationally constrained N1-arylsulfonyltryptamine derivatives as 5-HT6 receptor antagonists
    Derek C Cole
    Chemical and Screening Sciences, Wyeth Research, Pearl River, NY 10965, USA
    Bioorg Med Chem Lett 15:4780-5. 2005
  10. ncbi Acylguanidines as small-molecule beta-secretase inhibitors
    Derek C Cole
    Chemical and Screening Sciences, Wyeth Research, 401 N Middletown Road, Pearl River, New York 10965, USA
    J Med Chem 49:6158-61. 2006

Detail Information

Publications24

  1. ncbi Modification of the swern oxidation: use of a recyclable, polystyrene bound sulfoxide
    Derek C Cole
    Chemical Sciences, Wyeth Research, 401N Middletown Rd, Pearl River, NY 10965, USA
    Bioorg Med Chem Lett 12:1791-3. 2002
    ..The polystyrene bound sulfoxide may be used in Swern oxidation reactions, and the used reagent may be regenerated by oxidation with tert-butylhydrogen peroxide...
  2. ncbi (S)-N-(5-Chlorothiophene-2-sulfonyl)-beta,beta-diethylalaninol a Notch-1-sparing gamma-secretase inhibitor
    Derek C Cole
    Chemical and Screening Sciences, Wyeth Research, Pearl River, NY 10965, USA
    Bioorg Med Chem Lett 19:926-9. 2009
    ..5-fold) gamma-secretase inhibitor (S)-N-(5-chlorothiophene-2-sulfonyl)-beta,beta-diethylalaninol 7.b.2 (Abeta(40/42) EC(50)=28 nM), which is efficacious in reduction of Abeta production in vivo...
  3. ncbi Identification, characterization and initial hit-to-lead optimization of a series of 4-arylamino-3-pyridinecarbonitrile as protein kinase C theta (PKCtheta) inhibitors
    Derek C Cole
    Chemical and Screening Sciences, Wyeth Research, Pearl River, New York 10965, USA
    J Med Chem 51:5958-63. 2008
    ..Compound 4p also inhibited IL-2 production in antiCD3/anti-CD28 activated T cells enriched from splenocytes...
  4. ncbi Benzimidazole- and indole-substituted 1,3'-bipyrrolidine benzamides as histamine H3 receptor antagonists
    Derek C Cole
    Chemical Sciences, Wyeth Research, 401 N Middletown Rd Pearl River, NY 10965, United States
    Bioorg Med Chem Lett 20:1237-40. 2010
    ..Optimization of the physical properties of the series led to (S)-6n, with improved brain to plasma exposure and efficacy in both water intake and novel object recognition models...
  5. ncbi Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1 and S3 substrate binding pockets
    Derek C Cole
    Chemical and Screening Sciences, Wyeth Research, 401 N Middletown Road, Pearl River, NY 10965, USA
    Bioorg Med Chem Lett 18:1063-6. 2008
    ..a.1). We report here the initial hit-to-lead optimization of this hit and the SAR around the aryl groups occupying the S(1) and S(2') pockets leading to submicromolar BACE-1 inhibitors...
  6. ncbi Discovery of N1-(6-chloroimidazo[2,1-b][1,3]thiazole-5-sulfonyl)tryptamine as a potent, selective, and orally active 5-HT(6) receptor agonist
    Derek C Cole
    Chemical and Screening Sciences, Wyeth Research, 401 N Middletown Road, Pearl River, New York 10965, USA
    J Med Chem 50:5535-8. 2007
    ....
  7. ncbi N1-arylsulfonyl-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives are potent and selective 5-HT6 receptor antagonists
    Derek C Cole
    Chemical and Screening Sciences, Wyeth Research, Pearl River, NY 10965, USA
    Bioorg Med Chem Lett 15:379-83. 2005
    ..4 and 3.0 nM affinity, respectively, and antagonized the production of adenylate cyclase at sub-nanomolar concentrations...
  8. ncbi Discovery of 5-arylsulfonamido-3-(pyrrolidin-2-ylmethyl)-1H-indole derivatives as potent, selective 5-HT6 receptor agonists and antagonists
    Derek C Cole
    Chemical and Screening Sciences, Wyeth Research, 401 N Middletown Road, Pearl River, New York 10965, USA
    J Med Chem 48:353-6. 2005
    ..Within this class, several of the (R)-enantiomers were potent agonists having EC(50) values of 1 nM or less and functioning as full agonists while the (S)-enantiomers displayed moderate antagonist activity...
  9. ncbi Conformationally constrained N1-arylsulfonyltryptamine derivatives as 5-HT6 receptor antagonists
    Derek C Cole
    Chemical and Screening Sciences, Wyeth Research, Pearl River, NY 10965, USA
    Bioorg Med Chem Lett 15:4780-5. 2005
    ..Several of the N1-arylsulfonyl-3-(1-methylpyrrolidin-2-ylmethyl)-1H-indole derivatives behave as very potent antagonists ((S)-11r, (S)-11t; IC50 = 0.8, 1.0 nM)...
  10. ncbi Acylguanidines as small-molecule beta-secretase inhibitors
    Derek C Cole
    Chemical and Screening Sciences, Wyeth Research, 401 N Middletown Road, Pearl River, New York 10965, USA
    J Med Chem 49:6158-61. 2006
    ..Structure-based optimization led to the identification of potent analogs, such as 10d (BACE1 IC(50) = 110 nM)...
  11. ncbi Synthesis and PKCtheta inhibitory activity of a series of 4-indolylamino-5-phenyl-3-pyridinecarbonitriles
    Russell G Dushin
    Wyeth Research, Chemical Sciences, 401 N Middletown Road, Pearl River, NY 10965, USA
    Bioorg Med Chem Lett 19:2461-3. 2009
    ..This study led to the discovery of compound 12d, which had an IC(50) value of 18nM for the inhibition of PKCtheta...
  12. ncbi Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer's disease
    Scott C Mayer
    Chemical and Screening Sciences, and Discovery Neuroscience, Wyeth Research, CN 8000, Princeton, New Jersey 08543, USA
    J Med Chem 51:7348-51. 2008
    ..Further side chain modification afforded the potent Notch-1-sparing GSI begacestat (5), which was selected for development for the treatment of Alzheimer's disease...
  13. ncbi Discovery and initial optimization of 5,5'-disubstituted aminohydantoins as potent beta-secretase (BACE1) inhibitors
    Pawel Nowak
    Chemical Sciences, Wyeth Research, 401 N Middletown Road, Pearl River, NY 10965, United States
    Bioorg Med Chem Lett 20:632-5. 2010
    ..Lead optimization using structure-based focused libraries led to the identification of low nanomolar BACE1 inhibitors such as 20b with substituents which extend from the S(1) to the S(3) pocket...
  14. ncbi Discovery of potent and selective inhibitors of the mammalian target of rapamycin (mTOR) kinase
    Pawel Nowak
    Chemical Sciences, Wyeth Research, 401 N Middletown Road, Pearl River, New York 10965, USA
    J Med Chem 52:7081-9. 2009
    ..These pyrazolopyrimidines represent an exciting new series of mTOR-selective inhibitors with potential for development for cancer therapy...
  15. ncbi Acylguanidine inhibitors of beta-secretase: optimization of the pyrrole ring substituents extending into the S1' substrate binding pocket
    Lee D Jennings
    Chemical and Screening Sciences, Wyeth Research, 401 N Middletown Road, Pearl River, NY 10965, USA
    Bioorg Med Chem Lett 18:767-71. 2008
    ..We report here the optimization of guanidinyl functional group substituents on 1, leading to potent submicromolar BACE-1 inhibitors...
  16. ncbi Discovery of a novel series of Notch-sparing gamma-secretase inhibitors
    Anthony Kreft
    Chemical and Screening Sciences, Wyeth Research, CN 8000, Princeton, NJ 08543 8000, USA
    Bioorg Med Chem Lett 18:4232-6. 2008
    ..Lead optimization studies led to the discovery of analog 8e with improved gamma-secretase inhibitory potency and Notch-sparing selectivity...
  17. ncbi Synthesis and PKCtheta inhibitory activity of a series of 4-(indol-5-ylamino)thieno[2,3-b]pyridine-5-carbonitriles
    Diane H Boschelli
    Wyeth Research, Chemical and Screening Sciences, 401 N Middletown Road, Pearl River, NY 10965, USA
    Bioorg Med Chem Lett 18:2850-3. 2008
    ..Optimization of the groups at C-4 and C-2 led to analog 29, which has an IC(50) value of 7.5nM for the inhibition of PKCtheta...
  18. ncbi Novel 1-aminoethyl-3-arylsulfonyl-1H-pyrrolo[2,3-b]pyridines are potent 5-HT(6) agonists
    Ronald C Bernotas
    Chemical Sciences, Wyeth Research, 500 Arcola Road, Collegeville, PA 19426, USA
    Bioorg Med Chem 17:5153-63. 2009
    ..This compound also reduced adjunctive drinking behavior in the rat schedule-induced polydipsia assay, possibly predictive of efficacy in obsessive compulsive disorder and other anxiety related disorders...
  19. ncbi Identification of a new class of small molecule C5a receptor antagonists
    Jack J Chen
    Chemical Sciences, Wyeth Research, Pearl River, NY 10956, USA
    Bioorg Med Chem Lett 20:662-4. 2010
    ..The lead compounds in this series are selective and block C5a binding, C5a-promoted calcium flux in human neutrophils with nanomolar potency...
  20. ncbi A fluorescent assay suitable for inhibitor screening and vanin tissue quantification
    Benfang H Ruan
    Inflammation and Immunology, Pfizer Biotherapeutics R and D, Cambridge, MA 02140, USA
    Anal Biochem 399:284-92. 2010
    ..Preliminary screening of a library of 1280 pharmaceutically active compounds identified inhibitors with novel chemical scaffolds. This assay will be a powerful tool for target validation and drug lead identification and characterization...
  21. ncbi Synthesis of pyrazolo[1,5-alpha]pyrimidinone regioisomers
    Lori K Gavrin
    Department of Exploratory Medicinal Chemistry and Chemical Technologies, Wyeth Research, 200 CambridgePark Drive, Cambridge, Massachusetts 02140, USA
    J Org Chem 72:1043-6. 2007
    ..This work provides the experimentalist with complimentary synthetic pathways that afford either the pyrimidin-7-one or the pyrimidin-5-one regioisomer...
  22. ncbi Inhibition of the signal transducer and activator of transcription-3 (STAT3) signaling pathway by 4-oxo-1-phenyl-1,4-dihydroquinoline-3-carboxylic acid esters
    Jun Xu
    Oncology and Chemical and Screening Sciences, Wyeth Research, 401 North Middletown Road, Pearl River, New York 10965, USA
    J Med Chem 51:4115-21. 2008
    ..Compound 8 also inhibited cytokine induced JAK activation but did not inhibit BCR-ABL activated STAT5 phosphorylation in K562 cells...
  23. ncbi A FLIPR-based assay to assess potency and selectivity of inhibitors of the TEC family kinases Btk and Itk
    John Douhan
    Inflammation, Wyeth Research, Cambridge, MA 02140, USA
    Assay Drug Dev Technol 5:751-8. 2007
    ..Thus, the FLIPR assay described here can be used to assess, compare, and rank the potency and selectivity of inhibitors of Itk and Btk kinases...
  24. ncbi Biochemical, cellular, and in vivo activity of novel ATP-competitive and selective inhibitors of the mammalian target of rapamycin
    Ker Yu
    Discovery Oncology, Wyeth Research, Pearl River, New York 10965, USA
    Cancer Res 69:6232-40. 2009
    ....